Viemed Healthcare, Inc. Common Shares earnings per share and revenue
On Nov 05, 2025, VMD reported earnings of 0.09 USD per share (EPS) for Q3 25, missing the estimate of 0.09 USD, resulting in a -0.99% surprise. Revenue reached 71.91 million, compared to an expected 72.72 million, with a -1.11% difference. The market reacted with a -2.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 analysts forecast an EPS of 0.12 USD, with revenue projected to reach 78.48 million USD, implying an increase of 33.33% EPS, and increase of 9.13% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
What were Viemed Healthcare, Inc. Common Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Viemed Healthcare, Inc. Common Shares reported EPS of $0.09, missing estimates by -0.99%, and revenue of $71.91M, -1.11% below expectations.
How did the market react to Viemed Healthcare, Inc. Common Shares's Q3 2025 earnings?
The stock price moved down -2.64%, changed from $6.43 before the earnings release to $6.26 the day after.
When is Viemed Healthcare, Inc. Common Shares expected to report next?
The next earning report is scheduled for Mar 09, 2026.
What are the forecasts for Viemed Healthcare, Inc. Common Shares's next earnings report?
Based on 2
analysts, Viemed Healthcare, Inc. Common Shares is expected to report EPS of $0.12 and revenue of $78.48M for Q4 2025.